Jiangsu Hengrui Medicine Revenue

Jiangsu Hengrui Medicine had revenue of 7.21B CNY in the quarter ending March 31, 2025, with 20.14% growth. This brings the company's revenue in the last twelve months to 29.19B, up 25.16% year-over-year. In the year 2024, Jiangsu Hengrui Medicine had annual revenue of 27.98B with 22.63% growth.

Revenue (ttm)

29.19B

Revenue Growth

+25.16%

P/S Ratio

11.50

Revenue / Employee

1.44M

Employees

20,238

Market Cap

335.80B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	27.98B	5.16B	22.63%
Dec 31, 2023	22.82B	1.54B	7.26%
Dec 31, 2022	21.28B	-4.63B	-17.87%
Dec 31, 2021	25.91B	-1.83B	-6.59%
Dec 31, 2020	27.73B	4.45B	19.09%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Shenzhen Mindray Bio-Medical Electronics	35.59B
WuXi AppTec	39.59B
Zhangzhou Pientzehuang Pharmaceutical.,	10.76B
Aier Eye Hospital Group	21.81B
Sichuan Biokin Pharmaceutical	5.82B
Shanghai United Imaging Healthcare	10.43B
Yunnan Baiyao Group Co.,Ltd	40.10B
Beijing Wantai Biological Pharmacy Enterprise	1.89B

Revenue Rankings